MicroRNA-103a regulates the calcification of vascular smooth muscle cells by targeting runt-related transcription factor 2 in high phosphorus conditions.

calcification chronic kidney disease microRNAs runt-related transcription factor 2 vascular smooth muscle cells β-glycerophosphate

Journal

Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 15 10 2019
accepted: 24 05 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 11 8 2021
Statut: ppublish

Résumé

Vascular calcification, such as atherosclerosis, is a serious complication of chronic kidney disease that is characterized by tunica media calcification, and has gained increasing attention from researchers. The commonly observed association between vascular calcification and osteoporosis suggests a link between bone and vascular disorders. As microRNAs (miRNAs) have a wide range of gene regulation functions, such as cell proliferation, apoptosis, stress and transdifferentiation, the current study aimed to determine whether miRNAs play a vital role in the calcification and osteoblastic differentiation of rat thoracic aorta vascular smooth muscle cells (VSMCs). Gene expression analysis was performed on seven miRNAs (miR-29a, -30b, -103a, -125b, -133a, -143 and -211) that maybe potentially involved in the differentiation of smooth muscle cells into osteoblastic cells. The results showed that the levels of miR-29a, -30b, -103a, -125b and -143 were markedly reduced in the VSMC calcification model, particularly miR-103a, whereas runt-related transcription factor 2 (

Identifiants

pubmed: 34373722
doi: 10.3892/etm.2021.10468
pii: ETM-0-0-10468
pmc: PMC8343701
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1036

Informations de copyright

Copyright: © He et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Exp Ther Med. 2015 Mar;9(3):1028-1034
pubmed: 25667672
J Am Soc Nephrol. 2016 Mar;27(3):824-34
pubmed: 26187577
Mol Cell Biochem. 2014 May;390(1-2):69-74
pubmed: 24381059
Arch Biochem Biophys. 2014 Dec 15;564:173-83
pubmed: 25241053
Exp Cell Res. 2014 Apr 1;322(2):302-12
pubmed: 24486760
Circ Res. 2011 Apr 15;108(8):917-28
pubmed: 21350216
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Circ Res. 2011 Sep 2;109(6):697-711
pubmed: 21885837
J Cell Physiol. 2018 Oct;233(10):6929-6937
pubmed: 29693254
Atherosclerosis. 2012 Apr;221(2):387-96
pubmed: 22305260
PLoS Genet. 2013 May;9(5):e1003424
pubmed: 23658527
Contrib Nephrol. 2015;185:156-67
pubmed: 26023025
PLoS One. 2017 Mar 20;12(3):e0174138
pubmed: 28319142
Int J Artif Organs. 2009 Feb;32(2):81-6
pubmed: 19363779
J Bone Miner Res. 2015 Feb;30(2):330-45
pubmed: 25195535
Am J Kidney Dis. 2008 Sep;52(3):519-30
pubmed: 18514987
Am J Med Sci. 2015 Apr;349(4):292-7
pubmed: 25782334
J Am Soc Nephrol. 2007 Apr;18(4):1307-15
pubmed: 17344421
Am J Transl Res. 2018 Apr 15;10(4):1211-1219
pubmed: 29736214
DNA Cell Biol. 2018 Mar;37(3):199-209
pubmed: 29359964
J Am Heart Assoc. 2012 Dec;1(6):e003905
pubmed: 23316327
Circ Res. 2011 May 27;108(11):1378-80
pubmed: 21617134
Comp Biochem Physiol B Biochem Mol Biol. 2014 Mar;169:16-24
pubmed: 24333236
Am J Pathol. 2011 Oct;179(4):1594-600
pubmed: 21806957
Life Sci. 2019 Sep 1;232:116676
pubmed: 31340165
Kardiol Pol. 2015;73(1):1-6
pubmed: 25371301
Int J Nephrol. 2011;2011:758450
pubmed: 21716706
Braz J Med Biol Res. 2013 Aug;46(8):676-80
pubmed: 24036939
Bone. 2015 Jul;76:121-8
pubmed: 25868801
J Cardiovasc Pharmacol. 2015 Jul;66(1):63-71
pubmed: 25806689

Auteurs

Lei He (L)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Jinsheng Xu (J)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Yaling Bai (Y)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Huiran Zhang (H)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Wei Zhou (W)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Meijuan Cheng (M)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Dongxue Zhang (D)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Lu Zhang (L)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Shenglei Zhang (S)

Department of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Hebei Clinical Research Center for Chronic Kidney Disease, Shijiazhuang, Hebei 050011, P.R. China.

Classifications MeSH